Title : 4217C>A polymorphism in carbamoyl-phosphate synthase 1 gene may not associate with hyperammonemia development during valproic acid-based therapy.

Pub. Date : 2014 Aug

PMID : 24888247






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Polymorphisms in the genes encoding carbamoyl-phosphate synthase 1 (CPS1) and N-acetylglutamate synthase (NAGS) were recently reported to be risk factors for the development of hyperammonemia during valproic acid-based therapy. Valproic Acid N-acetylglutamate synthase Homo sapiens
2 Polymorphisms in the genes encoding carbamoyl-phosphate synthase 1 (CPS1) and N-acetylglutamate synthase (NAGS) were recently reported to be risk factors for the development of hyperammonemia during valproic acid-based therapy. Valproic Acid N-acetylglutamate synthase Homo sapiens